These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Effect of idebenone on scopolamine-induced impairment of short-term memory in rats]. Yamazaki N, Nagaoka A, Nagawa Y. Yakubutsu Seishin Kodo; 1985 Dec; 5(4):321-8. PubMed ID: 3832686 [Abstract] [Full Text] [Related]
8. Early-life undernutrition impairs the development of the learning and short-term memory processes mediating performance in a conditional-spatial discrimination task. Castro CA, Tracy M, Rudy JW. Behav Brain Res; 1989 Apr 01; 32(3):255-64. PubMed ID: 2496701 [Abstract] [Full Text] [Related]
9. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Raghavendra V, Chopra K, Kulkarni SK. Neuropeptides; 1998 Oct 01; 32(5):417-21. PubMed ID: 9845001 [Abstract] [Full Text] [Related]
10. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. Dennes RP, Barnes JC. Psychopharmacology (Berl); 1993 Oct 01; 111(4):435-41. PubMed ID: 7870985 [Abstract] [Full Text] [Related]
11. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Xiong ZQ, Tang XC. Pharmacol Biochem Behav; 1995 Oct 01; 51(2-3):415-9. PubMed ID: 7667362 [Abstract] [Full Text] [Related]
12. Short-term memory: facilitation and disruption with cholinergic agents. Alpern HP, Marriott JG. Physiol Behav; 1973 Oct 01; 11(4):571-5. PubMed ID: 4743228 [No Abstract] [Full Text] [Related]
13. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: evidence for a cholinergic mechanism. Stanford JA, Fowler SC. Neurosci Lett; 1997 Apr 11; 225(3):157-60. PubMed ID: 9147394 [Abstract] [Full Text] [Related]
14. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats. Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Pharmacol Biochem Behav; 1995 Aug 11; 51(4):739-46. PubMed ID: 7675853 [Abstract] [Full Text] [Related]
15. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine. Genovese RF. Eur J Pharmacol; 1990 Feb 13; 176(3):271-9. PubMed ID: 2328755 [Abstract] [Full Text] [Related]
16. Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment. Stemmelin J, Cassel JC, Will B, Kelche C. Behav Brain Res; 1999 Jan 13; 98(1):53-66. PubMed ID: 10210522 [Abstract] [Full Text] [Related]
17. Evidence against a specific effect of cholinergic drugs on spatial memory in primates. Rupniak NM, Samson NA, Tye SJ, Field MJ, Iversen SD. Behav Brain Res; 1991 Apr 18; 43(1):1-6. PubMed ID: 1859616 [Abstract] [Full Text] [Related]
18. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats. Shannon HE, Bemis KG, Hendrix JC, Ward JS. J Pharmacol Exp Ther; 1990 Dec 18; 255(3):1071-7. PubMed ID: 2262893 [Abstract] [Full Text] [Related]
19. Ontogenetic aspects of central cholinergic involvement in spontaneous alternation behavior. Egger GJ, Livesey PJ, Dawson RG. Dev Psychobiol; 1973 Jul 18; 6(4):289-99. PubMed ID: 4793359 [No Abstract] [Full Text] [Related]
20. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus). Muggleton NG, Bowditch AP, Crofts HS, Scott EA, Pearce PC. Psychopharmacology (Berl); 2003 Mar 18; 166(3):212-20. PubMed ID: 12589520 [Abstract] [Full Text] [Related] Page: [Next] [New Search]